Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The only natural host of the hepatitis C virus (HCV) is humans. Model organisms for laboratory studies, especially mice, cannot be infected, which makes the search for a vaccine against HCV extremely ...

There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could cure the hepatitis C infection. The NHS couldn’t afford to give it to everyone ...

et al, V. (2020): “Generalized Estimates of the Severity of Coronavirus Disease 2019: A Model Based Analysis,” available online. Feng, Z., W. Huang, and C. Castillo-Chavez (2005): “Global Behaviour of ...

This research aimed to examine the association between hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and liver inflammation in chronic hepatitis B (CHB) infection patients. Methods: ...

Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms ... Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, ...

Hepatitis C is an infectious disease of the liver caused by the hepatitis C virus (HCV). In the United States, it is the most common blood-borne infection, impacting around 2.4 million Americans, or ...